Blue Iris Labs has launched an updated website and is preparing a consumer-oriented pilot of the Speck W, a wearable light exposure sensor designed to help users understand daily light exposure patterns and how those patterns may relate to sleep and circadian health. Source: blueirislabs.com
Title: Using Light Exposure to Improve Sleep and Circadian Health for People with Dementia Authors: Erik Page, William Huang, Dave Harris, Hank Ibser
This is part of the monthly MassAITC webinar series. Abstract: Light exposure is the primary regulator of human circadian rhythms, influencing many aspects of our physiology and behavior, including sleep, alertness, and mood, as well as many neuroendocrine and cognitive functions. While we have evolved experiencing “bright days and dark nights,” most of us now experience significantly darker days and brighter nights than our pre-modern ancestors, likely resulting in widespread circadian disruption. And as we age, the relationship between light exposure, circadian rhythms, and sleep can be further compromised both through normal aging (e.g., less light reaching the retina due to clouding of the lens) and age-related risk factors, such as Alzheimer’s Disease (AD), which is known to damage the brain’s master clock. This webinar will review the current science related to light exposure, circadian…
Title: Using Light Exposure to Improve Sleep and Circadian Health for People with Alzheimer’s Disease Authors: Erik Page, William Huang, Dave Harris, Hank Ibser
Title: Speck: A Sensor for Healthier Lighting Authors: William Huang, Erik Page, Hank Ibsen, Dave Harris
US Patent office granted a patent to Blue Iris on March 19, 2024 for their Circadian Sensor System. A circadian health system (CHS) provides for improving the health of Alzheimer’s patients and other persons by controlling their exposure to circadian lighting. Circadian sensor devices (CSDs) are distributed in a living space, e.g., at about about eye-level positions on respective walls of room. Each CSD includes a spectral sensor for measuring the intensity of light at various wavelength bands. Captured spectra can be compared to circadian light signatures so that the sources of circadian light can be identified. The identifications then allow predetermined high-resolution, e.g., 5nm, spectra in the circadian wavelengths of 450-500 nm to be determined. The spectra can then be used to control circadian lighting to provide prescribed doses of circadian stimulus. Source: https://ppubs.uspto.gov/api/pdf/downloadPdf/11931172?requestToken=eyJzdWIiOiI0MzBhYjExNC00OTI0LTRjYjYtYWFkYy0yOGZjOTM2MDM2YjMiLCJ2ZXIiOiJhYzg0ODU3OS02NGRmLTRhNTgtYmZmOS0yNDlmNTFiMTQ2ODciLCJleHAiOjB9
Blue Iris has commercialized a new version of the Speck light exposure sensor. The new version is functionally similar to the previous version but has been modified for increased field robustness (e.g., more resilient power supply, stronger case, etc) and for manufacturing scalability. Source: Blue Iris Labs Product Page